TrialAntimicrobial agents and chemotherapy2012

Characterization of hepatitis C virus (HCV) quasispecies dynamics upon short-term dual therapy with the HCV NS5B nucleoside polymerase inhibitor mericitabine and the NS3/4 protease inhibitor danoprevir.

S Le Pogam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.